The people behind the approach

Medical advisory board.

Physicians change their prescribing in response to respected peers. We list confirmed leadership and advisors separately from KOL anchors still in engagement.

Founders & clinical leadership

Dr. Robert Bocian, MD, PhD

Chief Scientific Officer and co-founder

Stanford-trained allergist, FAAAAI

Roughly 30 years as an adjunct clinical associate professor at Stanford, with a Palo Alto practice. The authority anchor behind three decades of clinical refinement.

Dr. Shuba Iyengar, MD, MPH

Chief Medical Officer and co-founder

Stanford- and Harvard-trained allergist

Clinical leadership across the formulary and care model.

Note: Confirm exact public credential line before launch.

Advisors

Dr. Rafael Pelayo, MD

Sleep medicine advisor

Stanford Sleep Medicine; President, California Sleep Society

Author of How to Sleep. Sleep-medicine voice for the sleep track and educational programming.

Dr. Brad Hinrichs, MD

ENT advisor

ENT / otolaryngologist, Palo Alto Foundation Medical Group at Sutter Health

Otolaryngology voice; participant in Allermi's educational webinar.

KOL anchors (engagement in progress)

Dr. Fuad Baroody, MD

KOL anchor (engagement in progress)

University of Chicago ENT / rhinology

Principal investigator of the foundational oxymetazoline-plus-corticosteroid trial. Highest-priority anchor for the ENT and allergist tracks.

Note: Do not present as endorsing until formally confirmed.

Dr. Macario Camacho, MD

KOL anchor (engagement in progress)

Sleep medicine

Sleep-medicine anchor for the sleep track.

Note: Do not present as endorsing until formally confirmed.

Dr. Soroush Zaghi, MD

KOL anchor (engagement in progress)

Sleep surgeon, Los Angeles

Sleep-surgery reach for the sleep track.

Note: Do not present as endorsing until formally confirmed.